UPS Extends Complex Healthcare Logistics Lead with $48 Million Investment in Temperature-Controlled Freight Cross-Dock Facilities

About this update from United Parcel Service, Inc.

UPS (NYSE: UPS), the world’s No. 1 provider of complex healthcare logistics, today announced its $48 million investment in 27 temperature-controlled freight cross-dock facilities around the globe. Located in key U.S. and international markets, including Europe, Asia and the Americas, these facilities are optimized for speed and short-term storage between air and ground movements – all while maintaining specific temperature requirements. The announcement strengthens UPS’s global cold-chain network as demand grows for medicines requiring strict temperature ranges of 2 to 8 degrees Celsius, 15 to 25 degrees Celsius and frozen.Industry demand for temperature-sensitive biologics is projected to expand at an 8.3% compound annual growth rate through 2033, reaching an estimated $39.1 billion, according to Growth Market Reports. Meeting this demand requires cold-chain expertise to maintain product quality and safety from manufacturing to patient.“We have aligned our investments with our Healthcare customers’ specialized needs. Our global cross-dock facilities strengthen our end-to-end cold-chain capabilities to ensure critical treatments are delivered safely and reliably to patients around the world,” said Kate Gutmann, EVP and President of International, Healthcare and Supply Chain Solutions at UPS. “This effort – and all of our work in healthcare logistics – extends from a deep understanding that we’re doing more than moving packages. We are helping patients access the medications and treatments they need.”Single Provider, Total Control: Integrated Freight Cross-Docks Reduce Risk27 temperature-controlled freight cross-docks create seamless movement across transportation modes. All facilities are compliant with IATA CEIV Pharma certification, an industry-recognized standard for pharmaceutical handling and quality.A single integrated network eliminates handoffs between providers, reducing risk and increasing control.Greater accountability and real-time oversight protect high-value, temperature-sensitive therapies from excursion and disruption.24/7/365 control tower proactively monitors shipments, flags risks and enables rapid intervention to keep critical products moving.Rise of Advanced Therapies Accelerates Demand for Precision Cold-Chain SolutionsThe rapidly growing biologics pipeline is increasing complexity across cold-chain logistics. According to PharmaSour...

View stock analysis, news, and events for United Parcel Service, Inc.